Expertise in
6
conditions

Jenny G. Low

Third Hospital Avenue, 
Singapore, SG 
Expertise in
6
conditions
Third Hospital Avenue, 
Singapore, SG 
OverviewLocationsClinical Research

Overview

Jenny Low practices in Singapore, Singapore. Ms. Low is highly rated in 6 conditions, according to our data. Her top areas of expertise are Viral Hemorrhagic Fever, Dengue Fever, Yellow Fever, Zika Virus Disease, and Hepato-Pancreato-Biliary Surgery.

Her clinical research consists of co-authoring 57 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Female

Locations

Third Hospital Avenue, Singapore, 168752, Singapore

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Using GM-CSF as a Host Directed Therapeutic Against COVID-19 - a Phase 2 Investigator Initiated Trial
Using GM-CSF as a Host Directed Therapeutic Against COVID-19 - a Phase 2 Investigator Initiated Trial
Enrollment Status: Completed
Publish Date: May 10, 2022
Intervention Type: Drug, Other
Study Drug: Sargramostim
Study Phase: Phase 2
Phase 1 Time Lagged, Parallel-Group, Randomized, Placebo-Controlled, Single-Blind, Single Ascending Dose Study of Tyzivumab in ZIKV Infected Patients
Phase 1 Time Lagged, Parallel-Group, Randomized, Placebo-Controlled, Single-Blind, Single Ascending Dose Study of Tyzivumab in ZIKV Infected Patients
Enrollment Status: Withdrawn
Publish Date: March 24, 2022
Intervention Type: Other, Biological
Study Drug: Tyzivumab
Study Phase: Phase 1
Phase 1 First-in-Human, Time Lagged, Randomised, Placebo Controlled, Double Blind, Single Ascending Dose Study of TY027 in Healthy Adult Volunteers
Phase 1 First-in-Human, Time Lagged, Randomised, Placebo Controlled, Double Blind, Single Ascending Dose Study of TY027 in Healthy Adult Volunteers
Enrollment Status: Completed
Publish Date: April 08, 2021
Intervention Type: Biological, Other
Study Phase: Phase 1
Phase 1 First-in-Human, Time Lagged, Single Ascending Dose Study of TY014 in Healthy Adult Volunteers (Safety Arm - 1A) and Sequential Time Lagged, Parallel-Group, Randomised, Placebo-Controlled, Double-Blind, Single Ascending Dose Study of TY014 in YF-17D Vaccine Strain-Challenged Healthy Adult Volunteers (Efficacy Arm - 1B)
Phase 1 First-in-Human, Time Lagged, Single Ascending Dose Study of TY014 in Healthy Adult Volunteers (Safety Arm - 1A) and Sequential Time Lagged, Parallel-Group, Randomised, Placebo-Controlled, Double-Blind, Single Ascending Dose Study of TY014 in YF-17D Vaccine Strain-Challenged Healthy Adult Volunteers (Efficacy Arm - 1B)
Enrollment Status: Completed
Publish Date: October 25, 2019
Intervention Type: Biological, Other
Study Phase: Phase 1
View 3 Less Clinical Trials

57 Total Publications

Dengue and severe dengue.
Dengue and severe dengue.
Journal: Clinical microbiology reviews
Published: September 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Low's expertise for a condition
ConditionClose
    View All 7 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile